ГОСТ ISO 10993-4-2011
[81]Guide to the Preparation, Use and Quality Assurance of Blood Components.
Strasbourg: Council of Europe Publishing and Documentation Service, 1992, pp. 37 -
38
[82]Anticoagulant Citrate Dextrose Solution. U.S. Pharmacopeia 23, 1995, p. 119
[83] Anticoagulant and preservative solutions for human blood: Anticoagulant acid-
citrate-glucose solutions (ACD) and Anticoagulant citrate-phosphate-glucose
solution (CPD). European Pharmacopoeia 0209, 1997, pp. 400 - 403
[84]Anticoagulant Citrate Phosphate Dextrose Solution. U.S. Pharmacopeia 23, 1995,
pp. 119- 120
[85]Anticoagulant Citrate Phosphate Dextrose Adenine Solution, U.S. Pharmacopeia
23, 1995, pp. 121-122
[86]Anticoagulant Heparin Solution. U.S. Pharmacopeia 23, 1995, p. 122
[87]Anticoagulant Sodium Citrate Solution. U.S. Pharmacopeia 23, 1995, p. 122
[88]29 CFR, Code of Federal Regulations, 1910. 1030, Bloodborne Pathogens
[89] WENNBERG, A., HENSTEN-PETTERSEN, A., Sensitivity of erythrocytes from
various species to in vitro hemolyzation, J. Biomed. Mater. Res., 15, 1981, pp. 433 -
435
[90]A Colour Atlas of Comparative, Diagnostic and Experimental Haematology, Mosby-
Year Book Europe Limited, London, England, 1994
[91]Sterile plastic containers for human blood and blood components. European
Pharmacopoeia, 3.2.3, 1997, pp. 175-179
56